Emiel De Jaeghere

Journal Article
A1
open access

Identification of potentially actionable genetic variants in epithelial ovarian cancer : a retrospective cohort study

Charlotte Fieuws (UGent) , Joni Van der Meulen (UGent) , Kristiaan Proesmans (UGent) , Emiel De Jaeghere (UGent) , Siebe Loontiens (UGent) , Jo Van Dorpe (UGent) , Philippe Tummers (UGent) , Hannelore Denys (UGent) , Koen Van de Vijver (UGent) and Kathleen Claes (UGent)

(2024) NPJ PRECISION ONCOLOGY. 8(1).

Add to list

Sexual health in Belgian cervical cancer survivors : an exploratory qualitative study

Eline Naert (UGent) , Hans Van Hulle, Emiel De Jaeghere (UGent) , Marjolein Orije (UGent) , Sarah Roels, Rawand Salihi (UGent) , Koen J. Traen, Kristien Watty, Lise-Marie Kinnaer (UGent) , Hans Verstraelen (UGent) , et al.

(2024) QUALITY OF LIFE RESEARCH.

Add to list

A breath of relief : navigating the resolution of unexplained respiratory failure

Thor Hautekiet, Emiel De Jaeghere (UGent) , Nina Cardinaels (UGent) , Yannick Vande Weygaerde (UGent) , Dieter Stevens (UGent) , Eric Derom (UGent) and Pieter Depuydt (UGent)

(2023) Belgian Pneumology Days 2023, Abstracts. In Belgian Pneumology Days

Add to list

Vaginal morbidity, sexual functioning, and health-related quality of life in cervical cancer survivors : a cross-sectional multicenter study (VAMOS)

Eline Naert (UGent) , Alexander Decruyenaere (UGent) , Renée Bultijnck (UGent) , Emiel De Jaeghere (UGent) , Marjolein Orije (UGent) , Rawand Salihi (UGent) , Hans Verstraelen (UGent) , Philippe Tummers (UGent) , Hannelore Denys (UGent) and Katrien Vandecasteele (UGent)

(2023) SUPPORTIVE CARE IN CANCER. 31(12).

Add to list

Performance of MRI for detection of >=T1b disease in local staging of endometrial cancer

Leonie Van Vynckt, Philippe Tummers (UGent) , Emiel De Jaeghere (UGent) , Hannelore Denys (UGent) , Menekse GOKER (UGent) , Hendrickx Sigi, Eline Naert (UGent) , Rawand Salihi (UGent) , Koen Van de Vijver (UGent) , Gabriëlle van Ramshorst (UGent) , et al.

(2023) 29th European Symposium on Urogenital Radiology (ESUR 2023), Abstracts.

Add to list

Journal Article
A1
open access

Completion surgery after intensity-modulated arc therapy for locally advanced cervical cancer : long-term follow-up and update on surgical outcome and oncologic results of a unique tertiary care single-center retrospective cohort

Axel Van Damme, Julie Rombaut, Amin Makar (UGent) , Emiel De Jaeghere (UGent) , Eline Naert (UGent) , Hannelore Denys (UGent) , Rawand Salihi (UGent) , Philippe Tummers (UGent) and Katrien Vandecasteele (UGent)

(2023) WORLD JOURNAL OF SURGICAL ONCOLOGY. 21(1).

Add to list

Journal Article
A1
open access

Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma : results of the phase II PRIMMO study

Emiel De Jaeghere (UGent) , Sandra Tuyaerts, An M. T. Van Nuffel, Ann Belmans, Kris Bogaerts, Regina Baiden-Amissah, Lien Lippens (UGent) , Peter Vuylsteke, Stéphanie Henry, Xuan Bich Trinh, et al.

(2023) CANCER IMMUNOLOGY IMMUNOTHERAPY. 72(2). p.475-491

Add to list

2022-RA-638-ESGO Pembrolizumab with multimodal immunomodulation in chemotherapy-pretreated cervical, endometrial, and uterine cancer : the PRIMMO phase II trial

Emiel De Jaeghere (UGent) , Sandra Tuyaerts, Ann M.T. van Nuffel, Ann Belmans, Kris Bogaerts, Regina Baiden-Amissah, Peter Vuylsteke, Stéphanie Henry, Xuan Bich Trinh, Peter A. van Dam, et al.

(2022) INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. In International Journal of Gynecological Cancer 32(Supplement 2). p.A187-A188

Add to list

Journal Article
A1
open access

Mental health and quality of life among patients with cancer during the SARS-CoV-2 pandemic : results from the longitudinal ONCOVID survey study

Emiel De Jaeghere (UGent) , Heini Kanervo (UGent) , Roos Colman (UGent) , Wim Schrauwen (UGent) , Paulien West (UGent) , Nele Vandemaele (UGent) , Aglaja De Pauw (UGent) , Celine Jacobs (UGent) , Ingeborg Hilderson, Michael Saerens (UGent) , et al.

(2022) CANCERS. 14(4).

Add to list

Pembrolizumab, SBRT, and immunomodulation for recurrent and/or refractory cervical or endometrial carcinoma

Emiel De Jaeghere (UGent) , Sandra Tuyaerts, Ann M.T. Van Nuffel, Lien Lippens (UGent) , An Hendrix (UGent) , P. Vuylsteke, S. Henry, X.B. Trinh, P.A. Van Dam, S. Aspeslagh, et al.

(2021) ANNALS OF ONCOLOGY. In Annals of Oncology 32(Supplement 7). p.S1449-S1450

Academic Bibliography

Emiel De Jaeghere

Identification of potentially actionable genetic variants in epithelial ovarian cancer : a retrospective cohort study

Sexual health in Belgian cervical cancer survivors : an exploratory qualitative study

A breath of relief : navigating the resolution of unexplained respiratory failure

Vaginal morbidity, sexual functioning, and health-related quality of life in cervical cancer survivors : a cross-sectional multicenter study (VAMOS)

Performance of MRI for detection of >=T1b disease in local staging of endometrial cancer

Completion surgery after intensity-modulated arc therapy for locally advanced cervical cancer : long-term follow-up and update on surgical outcome and oncologic results of a unique tertiary care single-center retrospective cohort

Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma : results of the phase II PRIMMO study

2022-RA-638-ESGO Pembrolizumab with multimodal immunomodulation in chemotherapy-pretreated cervical, endometrial, and uterine cancer : the PRIMMO phase II trial

Mental health and quality of life among patients with cancer during the SARS-CoV-2 pandemic : results from the longitudinal ONCOVID survey study

Pembrolizumab, SBRT, and immunomodulation for recurrent and/or refractory cervical or endometrial carcinoma

Contents

Support

Contact